Skip to main content
. 2017 May 10;8(23):37761–37772. doi: 10.18632/oncotarget.17781

Table 4. Association of selected SNPs with duration of hospitalization for HDMTX treatment.

SNPs Mean ± SD (days) P
SLCO1B1 rs11045879 0.355
CC +TC 5.77 ± 1.39
TT 5.62 ± 1.21
SLCO1B1 rs4149056 0.634
TC+TT 5.72 ± 1.33
CC 5.46 ± 0.62
SLCO1B1 rs2306283 0.345
CC +TC 5.73 ± 1.35
TT 5.46 ± 1.04
SLCO1B1 rs10841753 0.988
TC+TT 5.72 ± 1.34
CC 5.72 ± 1.35
SLC19A1 rs1051266 0.544
AA +AG 5.69 ± 1.20
GG 5.79 ± 1.59
SLC19A1 rs3788200 0.339
AG+GG 5.75 ± 1.44
AA 5.58 ± 0.85
SLC19A1 rs1131596 0.522
TC+CC 5.68 ± 1.20
TT 5.79 ± 1.58
SLC19A1 rs2838958 0. 906
AG+GG 5.70 ± 1.19
AA 5.72 ± 1.62
ABCB1 rs1128503 0.006
TC+CC 5.92 ± 1.37
TT 5.51 ± 1.28
ABCB1 rs1045642 0.112
TC+TT 5.63 ± 1.33
CC 5.88 ± 1.34
ABCG2 rs2231137 0.094
AG+GG 5.67 ± 1.29
AA 6.18 ± 1.59

SNP: single nucleotide polymorphism.